Skip to main navigation

About

Strategic Assets

Team

Strategy

Investor Relations

Investor Overview Press Releases Events & Presentations Corporate Presentation Corporate Governance

Overview
Board of Directors
Management
Committee Composition

Stock Information

Overview
Analyst Coverage

SEC Filings Email Alerts Subscription Contact Us

Contact Us

Press Release Details

GlaxoSmithKline and Theravance commence MABA Phase IIb COPD study

Dec 21, 2010

GSK THRX MABA Release Final 2010Dec21.pdf 81.3 KB

Investor Relations
Press Releases
Events & Presentations
Corporate Governance
Stock Information
- Overview
- Analyst Coverage
SEC Filings
Email Alerts Subscription
Contact Us

Innoviva

Jun 18, 2026 11:12 AM EDT

Minimum 15 minutes delayed. Source: LSEG

Sign up to receive important email alerts & updates from Innoviva.

Download Library
RSS News Feeds
Print

© 2026 Innoviva. All rights reserved. Terms & Conditions | Privacy Policy | Contact © 2026 Innoviva. All rights reserved.